Glucotim LA Eye Drop

This formulation is intended for topical ophthalmic use and provides a sustained effect suitable for once or twice daily administration as prescribed. Patients should be advised to avoid contact with the tip of the dropper to prevent contamination and to remove contact lenses prior to instillation, waiting at least 15 minutes before reinsertion. Common adverse reactions may include ocular irritation, burning, stinging, dry eyes, and blurred vision.

Systemic absorption can occur and may result in cardiovascular or respiratory effects such as bradycardia, hypotension, or bronchospasm, particularly in susceptible individuals with asthma or chronic obstructive pulmonary disease. Glucotim LA Eye Drop should be used with caution in patients with cardiac or pulmonary conditions and is contraindicated in those with hypersensitivity to Timolol or other beta-blockers.

Regular monitoring of intraocular pressure and patient response is recommended to ensure therapeutic efficacy and safety.